784608008: Product containing precisely naphazoline hydrochloride 270 microgram/1 milliliter and pheniramine maleate 3.15 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline in ocular dose form (medicinal product form)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing histamine H1 receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing histamine H1 receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\...

\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\...

\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product containing azole (product)\Product containing imidazole (product)\Product containing naphazoline (medicinal product)\...

\Product containing naphazoline in ocular dose form (medicinal product form)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Product containing naphazoline and pheniramine (medicinal product)\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product manufactured as ocular dose form (product)\Product containing naphazoline in ocular dose form (medicinal product form)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing naphazoline (medicinal product)\...

\Product containing naphazoline in ocular dose form (medicinal product form)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution
\Product containing naphazoline and pheniramine (medicinal product)\Product containing only naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765084019 Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765085018 Product containing precisely naphazoline hydrochloride 270 microgram/1 milliliter and pheniramine maleate 3.15 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4641301000052119 feniraminmaleat 3,15 milligram/milliliter och nafazolinhydroklorid 270 mikrogram/milliliter, lösning för oftalmiskt bruk sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has manufactured dose form	Conventional release eye solution (dose form)	true	Inferred relationship	Some
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	räkning av bas i aktiv ingrediens	två	false	Inferred relationship	Some
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Is a	Naphazoline and pheniramine only product in ocular dose form	true	Inferred relationship	Some
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has basis of strength substance (attribute)	Naphazoline hydrochloride	true	Inferred relationship	Some	2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has precise active ingredient	Naphazoline hydrochloride	true	Inferred relationship	Some	2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	har täljarvärde för koncentrationsstyrka	3,15	false	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has basis of strength substance (attribute)	Pheniramine maleate	true	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Has precise active ingredient	Pheniramine maleate	true	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	har täljarvärde för koncentrationsstyrka	270	false	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765084019	Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765085018	Product containing precisely naphazoline hydrochloride 270 microgram/1 milliliter and pheniramine maleate 3.15 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4641301000052119	feniraminmaleat 3,15 milligram/milliliter och nafazolinhydroklorid 270 mikrogram/milliliter, lösning för oftalmiskt bruk	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)